{
  "paper_id": "PMC11826905",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826905/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. (1).",
      "caption": "Research design.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/a8edfd2b5db6/PRA-20-1-55_F1.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/a8edfd2b5db6/PRA-20-1-55_F1.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/a8edfd2b5db6/PRA-20-1-55_F1.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/a8edfd2b5db6/PRA-20-1-55_F1.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/a8edfd2b5db6/PRA-20-1-55_F1.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11826905/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/a8edfd2b5db6/PRA-20-1-55_F1.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. (2).",
      "caption": "Expression of SLC7A3 in cancer. (A) SLC7A3 expression in different types of cancer was investigated using the TIMER database. (B) Decreased expression of SLC7A3 in breast cancer compared to normal tissues in the GEPIA database. (C) SLC7A3 expression in breast cancer was examined by using the UALCAN database. (D) Immunohistochemical staining of SLC7A3 was performed in ER-positive breast cancer and normal breast tissues. Representative images are shown. Scare bars, 50Î¼m. (E) Analysis of SLC7A3 expression in ER-positive breast cancer and adjacent normal tissues based on IHC score. (F) SLC7A3 expression in breast cancer and normal tissues. *p<0.05, **p<0.01, ***p<0.0001.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/f64b6b214f47/PRA-20-1-55_F2.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/f64b6b214f47/PRA-20-1-55_F2.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/f64b6b214f47/PRA-20-1-55_F2.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/f64b6b214f47/PRA-20-1-55_F2.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/f64b6b214f47/PRA-20-1-55_F2.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11826905/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/f64b6b214f47/PRA-20-1-55_F2.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Fig. (3).",
      "caption": "Box plots evaluating SLC7A3 expression among different groups of patients based on clinical parameters using the UALCAN database. Analysis is shown for cancer stages (A), nodal metastasis status (B), TP53 mutation status (C), patient race (D), breast cancer subclasses (E), TNBC type (F), pathological subtypes (G), and menopause status (H). Abbreviations: BRCA: breast cancer; N0: no regional lymph node metastasis; N1: metastases in 1 to 3 axillary lymph nodes; N2: metastases in 4 to 9 axillary lymph nodes; N3: metastases in 10 or more axillary lymph nodes. TNBC-BL1: TNBC basal-like 1; TNBC-BL2: TNBC basal-like 2; TNBC-IM: TNBC immunomodulatory; TNBC-M: TNBC mesenchymal; TNBC-MSL: TNBC mesenchymal stem-like; TNBC-LAR: TNBC luminal androgen receptor; TNBC-UNS: TNBC unspecified. IDC: infiltrating ductal carcinoma; ILC: infiltrating lobular carcinoma; Mixed: mixed histology; Mucinous: mucinous carcinoma; Medullary: medullary carcinoma; Metaplastic: metaplastic carcinoma; INOS: infiltrating carcinoma not otherwise specified. *p<0.05, **p<0.01, ***p<0.001.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/8f7712c13492/PRA-20-1-55_F3.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/8f7712c13492/PRA-20-1-55_F3.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/8f7712c13492/PRA-20-1-55_F3.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/8f7712c13492/PRA-20-1-55_F3.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/8f7712c13492/PRA-20-1-55_F3.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11826905/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/8f7712c13492/PRA-20-1-55_F3.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Fig. (4).",
      "caption": "Survival curves evaluating the prognostic value of SLC7A3. (A) OS curves using the Human Protein Atlas. (B) OS curves using the GEPIA database. (C) OS curves using the UALCAN database. (D) DFS curves using the GEPIA database. (E) OS, RFS, DSS and DMFS curves using the PrognoScan database. Abbreviation: BRCA: breast cancer. All dotted lines represent confidence bands.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/dd55e0564528/PRA-20-1-55_F4.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/dd55e0564528/PRA-20-1-55_F4.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/dd55e0564528/PRA-20-1-55_F4.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/dd55e0564528/PRA-20-1-55_F4.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/dd55e0564528/PRA-20-1-55_F4.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11826905/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/dd55e0564528/PRA-20-1-55_F4.jpg"
    },
    "figure_5": {
      "figure_number": "Figure 5",
      "title": "Fig. (5).",
      "caption": "Survival curve evaluating the prognostic value of SLC7A3. (A) Survival curves using the Kaplan-Meier plotter database are shown for distant metastasis-free survival (DMFS), (B) recurrence-free survival (RFS), and (C) overall survival (OS).",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/ee6f6cf3deb8/PRA-20-1-55_F5.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/ee6f6cf3deb8/PRA-20-1-55_F5.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/ee6f6cf3deb8/PRA-20-1-55_F5.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/ee6f6cf3deb8/PRA-20-1-55_F5.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F5",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/ee6f6cf3deb8/PRA-20-1-55_F5.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11826905/images/figure_5.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/ee6f6cf3deb8/PRA-20-1-55_F5.jpg"
    },
    "figure_6": {
      "figure_number": "Figure 6",
      "title": "Fig. (6).",
      "caption": "(A and B) The gene-gene interaction network for SLC7A3 was constructed using GeneMANIA. (C) The PPI network of SLC7A3 was generated using STRING. (D and E) Survival curves using the cBioPortal database are shown for RFS and OS.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/e3beddf30307/PRA-20-1-55_F6.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/e3beddf30307/PRA-20-1-55_F6.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/e3beddf30307/PRA-20-1-55_F6.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/e3beddf30307/PRA-20-1-55_F6.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F6",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/e3beddf30307/PRA-20-1-55_F6.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11826905/images/figure_6.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/e3beddf30307/PRA-20-1-55_F6.jpg"
    },
    "figure_7": {
      "figure_number": "Figure 7",
      "title": "Fig. (7).",
      "caption": "GO and KEGG enrichment analysis for SLC7A3. (A) Top 20 GO enrichment terms in breast cancer. (B) Top 12 KEGG enrichment pathways in breast cancer. SLC7A3 inhibits the proliferation and invasion of breast cancer cells in vitro.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/fb05041d084d/PRA-20-1-55_F7.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/fb05041d084d/PRA-20-1-55_F7.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/fb05041d084d/PRA-20-1-55_F7.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/fb05041d084d/PRA-20-1-55_F7.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F7",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/fb05041d084d/PRA-20-1-55_F7.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11826905/images/figure_7.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e84/11826905/fb05041d084d/PRA-20-1-55_F7.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Among these cancer types, breast tumors exhibited the most significant differences, indicating a potentially prominent role of SLC7A3 in breast cancer (Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Using the GEPIA database, we further observed substantially lower SLC7A3 mRNA expression in breast cancer tissues compared to normal breast tissues (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Additionally, direct analysis of SLC7A3 expression in breast cancer and adjacent tissues using data from the UALCAN database, based on The Cancer Genome Atlas (TCGA), confirmed a significant decrease in SLC7A3 expression in breast cancer tissues (Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The level of SLC7A3 was visibly lower in breast invasive ductal carcinoma tissues compared to normal breast tissues (Fig. 2D) and showed a significant reduction in 31 pairs of tumor samples compared with adjacent normal samples (Fig. 2E).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel E",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel E",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel E",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The results revealed that SLC7A3 was expressed at low level in both breast and pancreatic cancers compared to normal tissues (Fig. 2F).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel F",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel F",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel F",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among these cancer types, breast tumors exhibited the most significant differences, indicating a potentially prominent role of SLC7A3 in breast cancer (Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Using the GEPIA database, we further observed substantially lower SLC7A3 mRNA expression in breast cancer tissues compared to normal breast tissues (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Additionally, direct analysis of SLC7A3 expression in breast cancer and adjacent tissues using data from the UALCAN database, based on The Cancer Genome Atlas (TCGA), confirmed a significant decrease in SLC7A3 expression in breast cancer tissues (Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The level of SLC7A3 was visibly lower in breast invasive ductal carcinoma tissues compared to normal breast tissues (Fig. 2D) and showed a significant reduction in 31 pairs of tumor samples compared with adjacent normal samples (Fig. 2E).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel E",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel E",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel E",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The results revealed that SLC7A3 was expressed at low level in both breast and pancreatic cancers compared to normal tissues (Fig. 2F).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel F",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel F",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel F",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Based on breast sample types, SLC7A3 expression was lower in primary breast cancer samples compared to normal tissues (Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A decrease in the expression of SLC7A3 was observed in breast cancer patients across stages 1, 2, 3, and 4, compared to normal controls (Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For breast cancer with nodal metastasis, where SLC7A3 expression was lower in patients with breast cancer classified as N0, N1, or N2, compared to N3 (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Both TP53 wild-type and TP53-mutant breast cancer patients showed a reduction in SLC7A3 expression compared with normal controls, with significantly lower SLC7A3 expression in TP53-mutant breast cancer patients (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Furthermore, SLC7A3 expression was decreased in breast cancer patients of Caucasian, Asian, and African-American ethnicity, with higher SLC7A3 levels observed in Caucasian patient tumors than in their African-American and Asian counterparts (Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Regarding breast cancer subtypes, HER2-positive tumors displayed a generally greater reduction in SLC7A3 expression compared to TNBC tumors and luminal breast cancer tumors (Fig. 3E).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Among the major subclasses, luminal tumors exhibited higher SLC7A3 expression than TNBC-luminal androgen receptor, HER2-positive, and TNBC tumors (Fig. 3F).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel F",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel F",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel F",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "SLC7A3 expression in infiltrating lobular carcinoma was higher than in most other pathological types of breast cancer (Fig. 3G), and SLC7A3 expression was higher in pre-menopausal tumors than in post-menopausal tumors (Fig. 3H).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel G",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel H",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel G",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel H",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel G",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel H",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Based on breast sample types, SLC7A3 expression was lower in primary breast cancer samples compared to normal tissues (Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A decrease in the expression of SLC7A3 was observed in breast cancer patients across stages 1, 2, 3, and 4, compared to normal controls (Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For breast cancer with nodal metastasis, where SLC7A3 expression was lower in patients with breast cancer classified as N0, N1, or N2, compared to N3 (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Both TP53 wild-type and TP53-mutant breast cancer patients showed a reduction in SLC7A3 expression compared with normal controls, with significantly lower SLC7A3 expression in TP53-mutant breast cancer patients (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Furthermore, SLC7A3 expression was decreased in breast cancer patients of Caucasian, Asian, and African-American ethnicity, with higher SLC7A3 levels observed in Caucasian patient tumors than in their African-American and Asian counterparts (Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Regarding breast cancer subtypes, HER2-positive tumors displayed a generally greater reduction in SLC7A3 expression compared to TNBC tumors and luminal breast cancer tumors (Fig. 3E).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Among the major subclasses, luminal tumors exhibited higher SLC7A3 expression than TNBC-luminal androgen receptor, HER2-positive, and TNBC tumors (Fig. 3F).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel F",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel F",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel F",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "SLC7A3 expression in infiltrating lobular carcinoma was higher than in most other pathological types of breast cancer (Fig. 3G), and SLC7A3 expression was higher in pre-menopausal tumors than in post-menopausal tumors (Fig. 3H).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel G",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel H",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel G",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel H",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel G",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel H",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Breast cancer patients with lower SLC7A3 expression, as determined by the median FPKM (fragments per kilobase million) value of TCGA data, exhibited a worse overall survival (OS) according to the Human Protein Atlas Kaplan-Meier analysis module (Fig. 4A).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Patients with higher expression of SLC7A3 had a better OS, according to the results of follow-up analysis (Fig. 4B and C).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The results revealed that breast cancer patients with high SLC7A3 expression had greater overall survival (OS), relapse-free survival (RFS), disease-specific survival (DSS), and distant metastasis-free survival (DMFS) compared to patients with low SLC7A3 expression, suggesting that SLC7A3 could act as a protective factor in breast cancer (Fig. 4E).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel E",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel E",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel E",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Breast cancer patients with lower SLC7A3 expression, as determined by the median FPKM (fragments per kilobase million) value of TCGA data, exhibited a worse overall survival (OS) according to the Human Protein Atlas Kaplan-Meier analysis module (Fig. 4A).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Patients with higher expression of SLC7A3 had a better OS, according to the results of follow-up analysis (Fig. 4B and C).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The results revealed that breast cancer patients with high SLC7A3 expression had greater overall survival (OS), relapse-free survival (RFS), disease-specific survival (DSS), and distant metastasis-free survival (DMFS) compared to patients with low SLC7A3 expression, suggesting that SLC7A3 could act as a protective factor in breast cancer (Fig. 4E).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel E",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel E",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel E",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "These genes include SLN, LRRC43, HEMGN, HHLA1, TDRD6, CRYBA1, NTNG1, SPATA19, and other members of the SLC family (Fig. 6A).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Functional analysis further demonstrated that these genes were related to L-type cationic amino acid transmembrane transporter activity (Fig. 6B).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Subsequently, a protein-protein interaction (PPI) network diagram for SLC7A3 was generated using the online STRING database, with 10 nodes representing proteins and 17 edges representing protein-protein associations (Fig. 6C).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The nodes included ARR3, COQ7, THOC7, CDX4, ZSCAN10, SLC7A13, SLC3A2, SLC1A4, SLC1A7, and SLC16A2 (Fig. 6C).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "These genes include SLN, LRRC43, HEMGN, HHLA1, TDRD6, CRYBA1, NTNG1, SPATA19, and other members of the SLC family (Fig. 6A).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Functional analysis further demonstrated that these genes were related to L-type cationic amino acid transmembrane transporter activity (Fig. 6B).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Subsequently, a protein-protein interaction (PPI) network diagram for SLC7A3 was generated using the online STRING database, with 10 nodes representing proteins and 17 edges representing protein-protein associations (Fig. 6C).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The nodes included ARR3, COQ7, THOC7, CDX4, ZSCAN10, SLC7A13, SLC3A2, SLC1A4, SLC1A7, and SLC16A2 (Fig. 6C).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 7,
    "claims_count": 40,
    "images_downloaded": 7,
    "tables_filtered": 45
  }
}